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Abstract  31 
It is well established that the CXCL9 and CXCL10, two chemokines that belong to the 32 
CXC family, are dysregulated in oral inflammatory conditions. It has not been 33 
established if these chemokines target the micro-organisms that form the oral biofilm. 34 
The aim of this study was thus to investigate the antimicrobial activity of CXCL9 and 35 
CXCL10 on oral microflora and their expression profile in oral keratinocytes following 36 
inflammatory and infectious stimuli.  Streptococcus sanguinis was used as a model and 37 
Escherichia coli as a positive control. The antimicrobial effect of CXCL9/CXCL10 was 38 
tested using radial diffusion assay. mRNA transcripts were isolated from LPS-treated 39 
and untreated (control) oral keratinocyte cell lines at 2, 4, 6 and 8 h. The CXCL9/10 40 
expression profile in the presence or absence of IFN-γ was assessed using semi-41 
quantitative PCR. Both chemokines demonstrated antimicrobial activity. CXCL9 was 42 
the most effective against both Strep. sanguinis/Ecoli. CXCL10 mRNA was expressed 43 
in control cells and its production was enhanced by LPS stimulation at all time-points. 44 
Conversely, CXCL9 mRNA was not expressed in control or LPS-stimulated cells. 45 
Finally, IFN-γ stimulation enhanced basal expression of both CXCL9 and CXCL10 in 46 
oral keratinocytes. Oral epithelial derived chemokines demonstrate antimicrobial 47 
properties, particularly CXCL9. Bacterial and inflammatory stimulated up-regulation 48 
of CXC9/10, with the potential to prevent adherence and invasion of oral epithelial 49 
 3 
cells, could represent a key element in oral bacterial colonization homeostasis and host 50 
defense mechanisms. 51 
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Introduction 60 
Bacteria colonize all surfaces of humans, but are particularly dense in lower 61 
gastrointestinal tract and in the oral cavity where Streptococci represent a large 62 
proportion of the resident microflora.  63 
It has previously been shown that bacteria can adhere and invade host oral epithelial 64 
cells (1) and furthermore, there are bacterial receptors present in saliva that can be 65 
absorbed onto oral mucosal surfaces (2). Among them, the toll like receptors (TLR) 66 
expressed on host cells are involved in the recognition of conserved bacterial patterns, 67 
for example the cell wall component of gram negative bacteria, lipopolysaccharide 68 
(LPS) (3).  69 
In order to counter bacterially-mediated tissue damage, keratinocytes produce a wide 70 
number of molecules encompassing antimicrobial peptides (AMPs), that are 71 
differentially regulated together with pro-inflammatory cytokines across epidermal 72 
layers following bacterial stimuli (4).  73 
 4 
The chemokines monokine induced by IFN-γ CXCL9, and IFN-γ-induced protein-10 74 
CXCL10 are two chemokines belonging to the CXC family, both binding the same 75 
CXCR3 receptor (5). Chemokines play an important role in directing the migration of 76 
specific immune cell populations and for some a direct anti-bacterial and/or -fungal 77 
activities has been demonstrated (6-8). As oral epithelial cells are known to produce 78 
chemokines (9-11) these may be playing a direct role in microbial defence.  79 
It is known that the CXC ELR- chemokines can be induced by LPS in some cell types 80 
(12), and that these chemokines are expressed during bacterial infections (13). It is also 81 
known that LPS is capable of inducing a range of cytokines and chemokines from 82 
epithelial cells predominately by signalling through TLR-4 (14).  83 
The induction of these chemokines may be triggered in response to an alteration in the 84 
microbial flora, which could in turn cause an ensuing immune cell infiltration. We 85 
recently found that CXCL9/10 are dysregulated in oral inflammatory disease (personal 86 
communication), but nothing is known about their antibacterial activity. Furthermore, 87 
while the induction of several cytokines in oral epithelial cells after LPSs stimulation 88 
was previously demonstrated (11,14-17), the role of CXCL9/10 in the infection and 89 
immunity of the oral cavity has never been investigated.  90 
Therefore the aim of this paper was to investigate the potential of CXC ELR- 91 
chemokines to mediate microbicidal activity on the gram positive Strep. sanguinis, one 92 
of the most prevalent residents of the oral microflora, and the chemokines expression 93 
in  oral keratinocytes after exposure to infectious and inflammatory stimuli.  94 
The CCR10 ligands CCL27 (CTACK) and CCL28 (MEC) are two C-C chemokines 95 
that bind the CCR10 receptor found to exert a potent antimicrobial activity 96 
against Candida albicans, Gram-negative bacteria, and Gram-positive bacteria (7). We 97 
used these two chemokines as positive controls. 98 
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 99 
Material and Methods 100 
 101 
Cell culture techniques 102 
Normal Human Oral keratinocytes (NHOK) cell culture.   103 
All normal oral mucosa was obtained from healthy patients attending the Oral Surgery 104 
Clinic, Eastman Dental Institute for routine third molar extraction. Three  different 105 
NHOK strains (NHOK1, NHOK2, NHOK3) were isolated from the excised normal 106 
tissue. The samples were cut into approximately 1mm3 pieces and culturing at 37oC 107 
/5% CO2 in keratinocyte basal medium-2 containing the recommended growth 108 
supplements (Biowittaker, Wokingham, UK). The epithelial cells were then detached 109 
using 0.25% trypsin - 1 mM EDTA. The viability of the keratinocytes was confirmed 110 
by trypan blue exclusion. All of the cell lines/strains were derived prior to 2001 and 111 
therefore were not subject to ethical committee approval in the UK (18). The study was 112 
approved by the internal research committee at Eastman Dental Institute, University 113 
Collage London. 114 
 115 
H357 cell culture 116 
The oral squamous cell carcinoma cell line, H357, was established by PRIME et al (19). 117 
This cell line was grown in the same medium as described for the NHOK. 118 
 119 
Bacterial cell culture and antimicrobial assessment 120 
All bacterial stocks were maintained frozen at -70°C in trypticase soy broth (TSB) 121 
(Becton Dickinson) supplemented with 0.6% yeast extract (YE) (Oxoid, 122 
Basingstoke,UK) and 10% glycerol (BDH). Cultures were checked weekly both 123 
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visually and by Gram-staining for contamination with other bacteria. Stocks of E. coli 124 
NCTC JM22 and Strep. sanguinis NCTC 10904 (provided by Dr.Rod McNab at the 125 
Eastman Dental Institute, University College London, UK) bacterium were plated upon 126 
an agar plates containing 3% TSB. They were grown for 48 h at 37°C / 5% CO2 and 127 
maintained by twice weekly subculture on TSB agar plates.  128 
Each E. coli colony was taken and resuspended into 50 ml of 3% TSB.  For the oral 129 
streptococci species 3 streaks of a cultured plate were resuspended into 10 ml of 3% 130 
TSB.  The cultures were shaken at 250 rpm at 37oC for 15-18 h.  50 ml of the E. coli 131 
culture or 2 ml of the oral streptococci species culture was transferred into 50 ml or 10 132 
ml of 3% TSB respectively. This was shaken at 250 rpm for 3.5 h at 37°C. After this 133 
time the culture was adjusted to an OD of 1 at 620 nm.  134 
To prepare the underlay, 50 ml of 100 mM sodium phosphate buffer, 5 g agarose, low 135 
EEO (Sigma, Poole, UK) and 5 ml 3% trypticase soy broth (TSB) were added to 1 litre 136 
of distilled water. Then the pH was then adjusted to 7.4, the agarose was dissolved by 137 
heating the solution in the microwave. Then the solution was dispensed into in 50 ml 138 
aliquots and autoclaved. The underlay aliquots were then stored at room temperature 139 
until use in the radial diffusion assays at which point they were heated in a microwave 140 
until fluid and then stored in a 60oC water bath. 141 
8 ml of E. coli or 16 ml of the streptococcal species was added to 5 ml of molten 142 
underlay and dispensed into a Petri dish, using a leveling tray.  This underlay was 143 
allowed to set, then 3 mm holes were punched in the gel, using 10 ml pipettes 144 
(Starstedt). 5 μl of test solution diluted in 0.01% acetic acid was added to the wells.  145 
10 g agarose, low EEO (Sigma, Poole, UK) was added to 6% TSB, aliquoted into 50 146 
ml and autoclaved. The overlay aliquots were then stored at room temperature prior the 147 
use in the radial diffusion assays. 148 
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This plate was incubated for 3 h at 37°C, before 5 ml of overlay was added to the plate 149 
and incubated at 37°C overnight.  150 
Radial diffusion assays were then performed, adding 5 µl of either recombinant human 151 
CXCL9/CXCL10/CCL27/CCL28 (all Peprotech EC, London, UK) or 0.01% acetic 152 
acid to the wells before incubating the plates. 100 μM tetracycline was used as a 153 
positive control for the assay. 154 
Images of the plates were taken using Alphaimager software and the zones around the 155 
cultures measured from 3 different points from the end of the well. 156 
 157 
IFN-γ cell treatment assay 158 
In a modification of the method utilised by ALTENBURG et al (20), the H357 cells were 159 
seeded at 8x104 cells / well in a Falcon 6 well plate (Becton Dickinson, Oxford, UK) 160 
with 3 ml of KBM-2 medium containing no hydrocortisone. The cells were incubated 161 
for at least 3-5 days until cell culture was 60-80% confluent. Medium containing 1000 162 
U ml−1 IFN- was added to 3 wells and control cell culture medium only was added to 163 
the remaining 3 wells. The cells were incubated for 48 h. The supernatant was extracted, 164 
centrifuged and stored at –70°C. The adherent cells were washed with PBS (Gibco Life 165 
Technologies, Paisley, UK) before 0.5 ml of Trireagent (Sigma, Poole, UK) were 166 
added.  The suspension was then removed and stored at –70°C. The RNA was isolated 167 
as described below. 168 
 169 
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CXCL9 and CXCL10 mRNA transcripts in oral epithelial cells in response to 170 
lipopolysaccharide (LPS) and  IFN-γ: mRNA isolation and semi-quantitative RT-171 
PCR 172 
mRNA transcripts for 18S, CXCL9 or CXCL10 were isolated from H357 cells without 173 
(CON) or treated with LPS (LPS) for 2, 4, 6 or 8 h. The RNA was extracted using TRI 174 
Reagent® (Sigma, Poole , UK) and 2 ml Pellet Paint Co-precipitant (Novagen, 175 
Nottingham, UK) to visualise the RNA pellet.  176 
Single strand cDNA synthesis was performed. 2 ml of RNA was added to 4 ml 177 
deoxynucleotides (dNTPs) (2.5 mM) (Sigma), 2 ml of random hexamers (50 mm) 178 
(Ambion, Texas, USA) and 9.5 ml dH2O. Then 1 ml of RNAaseIN (Ambion, Austin, 179 
Texas, USA), 2 ml 10x MuLVRT buffer and 0.5 ml M-MuLVRT (200 U ml−1) 180 
(Boehringer-Mannheim, Germany) was added and incubated at 42oC for 1 h. 181 
RT-PCR for 18S, CXCL9 and CXCL10: Magnesium concentration was optimised for 182 
each primer as follows; 1 ml of cDNA was added to 4 ml dNTP (2.5 mM), 5 ml 10x 183 
buffer, 0.225 ml AmpliTaq (5.0 U ml−1) (Perkin Elmer), 4 ml of each specific primer 184 
(5 mM), 1.5 mM, 3.0 mM or 4.5 mM MgCl in each reaction and dH2O added to give a 185 
final volume of 50 ml. The products were separated on a 2% agarose (GibcoBRL Life 186 
Technologies, Paisley, UK) gel and visualised by staining with ethidium bromide 187 
(Sigma, Poole, UK), specific bands were visualised by ultra-violet trans-illumination 188 
in a MultiImage Light Cabinet (AlphaInnotech Corp., Cannock, UK) and digital images 189 
acquired and stored using AlphaImager Software (AlphaInnotech Corp., Cannock, 190 
UK).  191 
CXCL9 (5’-ccaacaccccacagaagtgc–3’, 5’-gccagcacctgctctgagac-3’), CXCL10 (5’- 192 
gccaattttgtccacgtgttg-3’, 5’-aaagaatttgggccccttgg-3’), and 18S ribosomal RNA (5’- 193 
tttcggaactgaggccatga-3’, 5’- gcatgccagagtctcgttcg -3’) primers were generated for use 194 
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in this study (Genosys-Sigma, Poole, UK). The thermocycler (Techne Genius; 195 
Cambridge, UK) parameters utilised were at 94oC for 45 s, 57oC for 45 s, 72oC for 45 196 
s.  197 
For each primer the linear range was determined by repeating the above reaction with 198 
optimised magnesium concentration for each primer and stopping the reaction at 15, 199 
17, 19, 21, 23, 25, 27, 29, 31, 33 and 35 cycles.  The mid-point of each linear range was 200 
determined by using intensity analysis of the bands with AlphaImager software, and 201 
this cycle length was utilised for each primer in subsequent reactions.  18S primer and 202 
18S Competitor primers (Ambion, Texas, USA) were combined to ratios 1:9, 2:8 and 203 
3:7 respectively. For each of the primers CXCL9/10, 4 ml of the 18S primer: competitor 204 
mix was added to the RT-PCR reaction. The band intensity of the 18S and specific 205 
primer was quantified for each primer in each sample with Phoretix 1D software 206 
(Phoretix, Newcastle, UK).       207 
Unless otherwise specified all the experiments were performed at least in triplicate.  208 
 209 
 210 
Results 211 
CXCL9 and CXCL10 mRNA transcripts in an oral epithelial cell line in response to 212 
IFN-γ 213 
The production of CXCL9/10 chemokines in oral mucosal keratinocytes was first 214 
assessed over time in preliminary experiments using the keratinocyte cell line H357 215 
(Supplementary Figure 1). CXCL10 mRNA levels in H357 cells were detected as early 216 
as 3 h after IFN-γ treatment and appeared to peak at 24 h. In contrast, the control cells 217 
showed virtually undetectable mRNA levels over the same time period. CXCL9 mRNA 218 
transcripts demonstrated a similar pattern to CXCL10, with a biphasic pattern showing 219 
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a rapid induction of mRNA in the stimulated cells followed by a second peak at 24/48 220 
h. Thus, the expression of CXCL9/10 in H357 cells can be significantly enhanced by 221 
IFN-γ in a time-dependent manner, with a peak after 48 h (Figure 1). Similar results 222 
were obtained in primary normal oral keratinocytes (NHOK) (Figure 2). These data 223 
were confirmed at the protein level by ELISA (data not shown). These results show that 224 
the expression of CXCL9/10 in oral epithelial cells are significantly enhanced by IFN-225 
γ in a time-dependent manner. 226 
 227 
CXCL9 and CXCL10 mRNA transcripts in an oral epithelial cell line in response to 228 
LPS 229 
CXCL10 mRNA was expressed in control cells (without LPS exposure), but was 230 
enhanced in response to LPS stimulation after 2, 4 and 6 h incubation. This expression 231 
subsequently decreased after 8 h of stimulation (Figure 3). In contrast, CXCL9 mRNA 232 
was not expressed in either control or LPS-stimulated cells at any of the time-points 233 
tested.  234 
 235 
 236 
Antimicrobial effect of CXCL9, CXCL10, CCL27 or CCL28 upon Strep. sanguinis and 237 
E. coli  238 
CCL27 and CCL28 were used as positive controls.  The clear zones of bacterial growth 239 
depletion that were produced after antimicrobial activity of the chemokines are 240 
indicated in Figure 4 and Figure 5. All of the chemokines tested demonstrated a level 241 
of antimicrobial activity at the tested concentration (Table 1). CXCL9 was the most 242 
effective of the tested chemokines against both Strep. sanguinis and E. coli. CCL27 and 243 
CXCL10 had a less effective antimicrobial action against Strep. sanguinis compared to 244 
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E.coli. CCL28 had the greatest antimicrobial action against E. coli. These results clearly 245 
demonstrate that the epithelial-derived chemokines CXCL9/10 exert antimicrobial 246 
activity.   247 
 248 
Discussion 249 
Chemokines are known to have antimicrobial effects but little is known of the action of 250 
chemokines derived from the oral mucosal epithelium. The present study is the first to 251 
examine the expression of CXC ELR- chemokines by oral epithelial cells when 252 
stimulated by bacteria-derived products such as LPS. The present study has established 253 
that a cell line of oral origin is capable of expressing mRNA of CXCL9/CXCL10 when 254 
stimulated with LPS. The production of these chemokines was also enhanced by  255 
inflammatory stimuli such as IFN-γ stimulation.  256 
CXCL10 mRNA expression was increased in H357 cells after LPS stimulation, 257 
whereas CXCL9 mRNA expression was not induced over the same time-period. 258 
Previously we have shown that CXCL10 can act as a potent chemoattractant of 259 
lymphocytes, hence this local production of CXCL10 by oral epithelial cells in response 260 
to LPS could have important effects upon oral inflammation, perhaps crucially in the 261 
initial stages of inflammation. 262 
Previous studies have also shown that LPS treatment alone can induce or enhance 263 
CXCL10 mRNA expression in several different cell types (12,21-23). However, in 264 
contrast to the present findings, LPS stimulation did not induce CXCL10 from cultured 265 
skin keratinocytes (24), suggesting perhaps that oral keratinocytes are more responsive 266 
to LPS stimulation than cutaneous keratinocytes. This difference in expression may 267 
reflect the high bacterial load in the oral cavity. 268 
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The rapid expression of mRNA of CXCL10 observed in the present study accords with 269 
that of murine macrophages (17,25) although LPS stimulation may be more transient 270 
than IFN-γ in CXCL10 production (10). This short-term effect may be essential to avoid 271 
over-stimulation of CXCL10 in response to resident bacteria in proximity to the 272 
epithelium. IL-10 is known to be able to down-regulate production of LPS-induced 273 
CXCL10 in macrophages (22). This cytokine is present within oral lichen planus (OLP) 274 
lesions and is increased in serum and saliva from patients with oral lichen planus (26), 275 
and thus may act to down-regulate expression of CXCL10 in oral inflammation.  276 
There are few reports of LPS-induced production of CXCL9. The present study 277 
revealed that CXCL9 mRNA was not expressed by H357 cells when stimulated with 278 
LPS. In contrast to the present study, CXCL9 mRNA was found to be expressed in 279 
LPS-stimulated murine dendritic cells (12), however, in another study, this chemokine 280 
was not induced in the same murine cell line by LPS, despite induction of CXCL9 by 281 
IFN-γ (25).  282 
It is possible that CXCL9 displays a delayed response in comparison to CXCL10, as 283 
CXCL9 mRNA induction in lung tissue of intravenously LPS-treated mice displays a 284 
later induction to CXCL10, and is never expressed to the same levels as CXCL10 (25).  285 
Many studies report that LPS and IFN-γ act synergistically to induce the production of 286 
high levels of CXCL10 mRNA, for example, in breast carcinoma cells (21,22). It is 287 
then possible that CXCL10 levels could be enhanced in oral inflammation where there 288 
is a presence of both LPS and IFN-γ, perhaps through the enhancement of specific 289 
TLRs (27). 290 
Gram-positive bacteria, such as Strep. sanguinis contain components other than LPS 291 
that are known to stimulate chemokine release from various cell types and it would be 292 
interestingly to determine whether these are also capable of stimulating the production 293 
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of the CXC ELR- chemokines in oral epithelium. Many gram-positive bacterial 294 
components act on a different toll like receptor, TLR-2, which is functionally expressed 295 
upon keratinocytes (28). However, TLR-2 agonists do not induce CXCL 10 production 296 
in macrophages (29) or dendritic cells (30) in vitro. This suggests that TLR-2 agonistic 297 
bacterial products would also not induce CXCL10 in epithelial cells.  Therefore, only 298 
products bound by TLR-4 would be influential in upregulating CXCL10 production in 299 
epithelial cells. In addition, as LPS-mediated CXCL10 production is TLR-4 dependant, 300 
it strongly suggests that oral keratinocytes bear functional TLR-4, therefore, LPS-301 
stimulation of epidermal cells is not due to TLR-2 agonist contaminants in LPS 302 
preparations, as previously suggested (28).  303 
Chemokine modulation in oral cells by bacterial products is thus complex and many 304 
different factors, including T cell contact, may play a factor in chemokine induction 305 
during an immune response.  306 
The present studies suggest that in certain circumstances, bacterial products could 307 
stimulate oral epithelial cells to produce an inflammatory response through TLR-4 308 
agonists (perhaps after continuous TLR-2 stimulation) and this may induce epithelially-309 
derived CXCL10-mediated inflammation. This inflammation would presumably be 310 
characterised by activated memory T cell infiltration localised under the basal 311 
epithelium reminiscent of the pathology of OLP.  312 
CXCL9 was shown to be a potent antimicrobial agent against both Strep. sanguinis and 313 
E. coli, as did CXCL10 but to a lesser degree, confirming the study by COLE et al (6). 314 
Although only one oral bacterial species was tested in the present study, the data hints 315 
that antimicrobial properties of these chemokines may assist in countering bacterial 316 
growth in the oral cavity.  317 
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The choice of using S. sanguinis as a model has been driven by the delicate role that 318 
this bacterium plays in the maintenance of the oral flora balance. It is commonly found 319 
in healthy tissues as pioneer colonizer as well as it is implicated in modulating the 320 
virulence of bacterial biofilms (31). Furthermore, significant inhibitory effects of the 321 
intracellular proteins produced by S. sanguinis on the growth and the morphology of 322 
many other components of the oral flora, such as P. intermedia, P. gingivalis, C. 323 
albicans, C. tropicalis and their biofilms have been demonstrated (32,33). This allow 324 
us to conjecture and  expect a series of chain effects if the CXCL9/10 antimicrobial 325 
activity is transferred in an in vivo model. As previously showed for the two 326 
chemokines CCL27 and CCL28, for which a wide spectrum of antimicrobial activity is 327 
well established, the action of CXCL9/10 expected against other micro-organisms of 328 
the oral cavity should follow a similar pattern (34). 329 
The low production of CXCL9 by oral epithelial cells following IFN-γ or LPS 330 
stimulation could potentially be a means of avoiding an over-active anti-microbial 331 
response due to the potent antimicrobial activity of CXCL9.  332 
In our study both CCL27/CCL28 showed to exert antimicrobial properties against E. 333 
coli and Strep. sanguinis. CCL28 has been shown to have a microbicidal activity 334 
against a wide range of bacteria (both Gram-negative and Gram-positive) and yeasts 335 
(7, 35), and our findings confirmed that this chemokine was also effective against the 336 
oral commensal Strep. sanguinis. This is only the second report of the antimicrobial 337 
effect of CCL28 upon the enterobacterial E. coli after the study reported by BERRI et al 338 
in 2014 (35). 339 
The production of CXCL10 by oral epithelial cells, in inflammatory conditions such as 340 
OLP, may be induced by resident bacteria that contain TLR-4 agonists. If this 341 
inflammation resulted from constant TLR-2 stimulation, this may cause a CXCL10 342 
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based inflammation and a resultant influx of memory Th1 CD4+ cells. Furthermore, 343 
CXCL10 is antimicrobial at high concentrations. It may be upregulated by the presence 344 
of bacteria, thus playing a role in defense of oral epithelial cells. The antimicrobial 345 
activity of the chemokines tested is likely to be an important mechanism in the 346 
homeostasis of oral bacterial colonisation. Any IFN-γ in the oral epithelial area (which 347 
could presumably be produced by the infiltrating Th1 cells) may synergise with TLR-348 
4 agonists to cause an increased inflammatory state. Further studies are still warranted 349 
to confirm these novel findings. 350 
  351 
 352 
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Figure legends: 488 
Figure 1: 18S, CXCL9 and CXCL10 mRNA expression in the H357 cell line either 489 
interferon-gamma treated for 48 h (IFN) or control cells that were left untreated (CON) 490 
over the same time period. The left column “m.w.” indicates the molecular weight 491 
(marker column). 492 
 21 
 493 
Figure 2: CXCL9 and CXCL10 mRNA expression in 3 different normal human oral 494 
keratinocytes (NHOK1, NHOK2, NHOK3) either interferon-gamma treated for 48 h 495 
(IFN) or control cells that were left untreated for 48 h (CON). The values were 496 
normalized against 18S mRNA expression used as house keeping. 497 
 498 
Figure 3: a) CXCL9 and CXCL10 expression by H357 cells with or without LPS 499 
stimulation: mRNA transcripts for 18S, CXCL9 or CXCL10 in H357 cells without 500 
(CON) or treated with LPS (LPS) for 2, 4, 6 or 8 h. b) Densitometric analysis of 501 
CXCL10 mRNA relative to 18S expression with (grey) and without (blue) LPS 502 
treatment. 503 
 504 
Figure 4: Radial diffusion gels demonstrating the antimicrobial activity of 100 µg ml−1 505 
human recombinant CXCL9, CXCL10, CCL27 and CCL28 upon Strep. sanguinis and 506 
E. coli bacterium. The negative control (-ve) contains 0.01% of acetic acid only. The 507 
diameter of the cleared zone around the well containing chemokine represents the 508 
antimicrobial properties of the chemokine. 509 
 510 
Figure 5: The antimicrobial activity of CXCL9 on E. coli JM22 bacterium at 50, 10, 511 
and 1 µM. 0 µM contains 0.01% of acetic acid only.  512 
 513 
Supplementary Figure 1: 18S, CXCL9 and CXCL10 mRNA expression in the H357 514 
cell line. (ifn)= cells that were treated with interferon-gamma  for 3, 6, 9, 24, 48 or 72 515 
h; (con)= control cells that were left untreated over the same time period.  516 
 517 
